Patrick Chames

5.7k total citations · 1 hit paper
91 papers, 4.3k citations indexed

About

Patrick Chames is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, Patrick Chames has authored 91 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Radiology, Nuclear Medicine and Imaging, 55 papers in Molecular Biology and 27 papers in Immunology. Recurrent topics in Patrick Chames's work include Monoclonal and Polyclonal Antibodies Research (63 papers), Advanced Biosensing Techniques and Applications (24 papers) and Glycosylation and Glycoproteins Research (20 papers). Patrick Chames is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (63 papers), Advanced Biosensing Techniques and Applications (24 papers) and Glycosylation and Glycoproteins Research (20 papers). Patrick Chames collaborates with scholars based in France, Russia and Netherlands. Patrick Chames's co-authors include Daniel Baty, Étienne Weiss, Marc Van Regenmortel, Hennie R. Hoogenboom, Klervi Even-Desrumeaux, Ralph A. Willemsen, Brigitte Kerfélec, Igor Nabiev, Alyona Sukhanova and Reno Debets and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Patrick Chames

87 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic antibodies: successes, limitations and hopes for the future

2009 1.1k citations Patrick Chames, Daniel Baty et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Chames France	34	2.5k	2.0k	1.3k	1.2k	478	91	4.3k
Paul J. Carter United States	22	2.9k 1.2×	2.8k 1.4×	1.2k 0.9×	1.3k 1.1×	344 0.7×	42	4.8k
Robert F. Kelley United States	48	4.5k 1.8×	2.2k 1.1×	1.5k 1.1×	865 0.7×	213 0.4×	101	6.5k
Daniel Baty France	37	3.2k 1.3×	1.7k 0.8×	1.0k 0.8×	829 0.7×	539 1.1×	120	5.0k
Nick Devoogdt Belgium	51	3.3k 1.3×	5.1k 2.6×	2.1k 1.6×	2.7k 2.3×	961 2.0×	155	8.2k
Herren Wu United States	40	3.0k 1.2×	3.0k 1.5×	1.3k 1.0×	1.3k 1.1×	269 0.6×	115	5.8k
Étienne Weiss France	25	1.9k 0.8×	1.1k 0.6×	522 0.4×	516 0.4×	269 0.6×	71	3.0k
Susan L. Deutscher United States	30	2.2k 0.9×	1.4k 0.7×	866 0.6×	594 0.5×	270 0.6×	83	3.6k
Rob C. Roovers Netherlands	32	2.6k 1.0×	2.5k 1.2×	1.1k 0.8×	1.0k 0.8×	318 0.7×	49	4.2k
Mitchell Ho United States	47	2.6k 1.0×	1.4k 0.7×	1.7k 1.2×	2.1k 1.8×	1.1k 2.4×	142	6.5k
Daniel Christ Australia	31	2.0k 0.8×	1.3k 0.7×	1.3k 1.0×	434 0.4×	148 0.3×	78	3.7k

Countries citing papers authored by Patrick Chames

Since Specialization

Citations

This map shows the geographic impact of Patrick Chames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Chames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Chames more than expected).

Fields of papers citing papers by Patrick Chames

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Chames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Chames. The network helps show where Patrick Chames may publish in the future.

Co-authorship network of co-authors of Patrick Chames

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Chames. A scholar is included among the top collaborators of Patrick Chames based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Chames. Patrick Chames is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biarnes‐Pelicot, Martine, Brigitte Kerfélec, Pierre‐Henri Puech, et al.. (2025). Decoupling Individual Host Response and Immune Cell Engager Cytotoxic Potency. ACS Nano. 19(2). 2089–2098.

Tapia‐Galisteo, Antonio, Anaïs Jiménez-Reinoso, Marta Compte, et al.. (2024). Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. OncoImmunology. 13(1). 2338558–2338558. 8 indexed citations

Perret, Pascale, Sabine Chierici, P. Millet, et al.. (2024). A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerization. Journal of Translational Medicine. 22(1). 163–163. 3 indexed citations

Wang, Yong‐Jian, Claire Valotteau, Terence R. Strick, et al.. (2023). Combining DNA scaffolds and acoustic force spectroscopy to characterize individual protein bonds. Biophysical Journal. 122(12). 2518–2530. 8 indexed citations

Xu, Chanjuan, Pauline Scholler, Jérôme A. J. Becker, et al.. (2022). Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain. Nature Chemical Biology. 18(8). 894–903. 29 indexed citations

Font, Joan, Robert B. Quast, Pauline Scholler, et al.. (2021). A nanobody activating metabotropic glutamate receptor 4 discriminates between homo- and heterodimers. Proceedings of the National Academy of Sciences. 118(33). 18 indexed citations

Bode, Julia, Alyona Sukhanova, Svetlana Bozrova, et al.. (2018). Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots. Scientific Reports. 8(1). 4595–4595. 32 indexed citations

Scholler, Pauline, Damien Névoltris, Dimitri De Bundel, et al.. (2017). Allosteric nanobodies uncover a role of hippocampal mGlu2 receptor homodimers in contextual fear consolidation. Nature Communications. 8(1). 1967–1967. 61 indexed citations

Moreau, Alain, Laurence Meyer, Cécile Goujard, et al.. (2014). Adaptation of HIV-1 Envelope Glycoprotein gp120 to Humoral Immunity over the Course of the Epidemic. AIDS Research and Human Retroviruses. 30(S1). A224–A224.

10.

Chames, Patrick, et al.. (2014). A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy. Oncotarget. 5(14). 5304–5319. 36 indexed citations

11.

Rakovich, Tatsiana, Bashir M. Mohamed, Adriele Prina‐Mello, et al.. (2014). Highly Sensitive Single Domain Antibody–Quantum Dot Conjugates for Detection of HER2 Biomarker in Lung and Breast Cancer Cells. ACS Nano. 8(6). 5682–5695. 83 indexed citations

12.

Cornillon, Amélie, Martine Chartier, Ghislaine Béhar, et al.. (2013). Single-Domain Antibody–Based and Linker-Free Bispecific Antibodies Targeting FcγRIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells. Molecular Cancer Therapeutics. 12(8). 1481–1491. 58 indexed citations

13.

Chames, Patrick. (2012). Antibody engineering : methods and protocols. Humana Press eBooks. 15 indexed citations

14.

Even-Desrumeaux, Klervi, Patrick Fourquet, Véronique Secq, Daniel Baty, & Patrick Chames. (2012). Single-domain antibodies: a versatile and rich source of binders for breast cancer diagnostic approaches. Molecular BioSystems. 8(9). 2385–2394. 26 indexed citations

15.

Even-Desrumeaux, Klervi, Daniel Baty, & Patrick Chames. (2010). Strong and oriented immobilization of single domain antibodies from crude bacterial lysates for high-throughput compatible cost-effective antibody array generation. Molecular BioSystems. 6(11). 2241–2248. 29 indexed citations

16.

Chames, Patrick & Daniel Baty. (2009). Bispecific antibodies for cancer therapy. mAbs. 1(6). 539–547. 270 indexed citations

17.

Béhar, Ghislaine, Sophie Sibéril, Patrick Chames, et al.. (2007). Isolation and characterization of anti-Fc RIII (CD16) llama single-domain antibodies that activate natural killer cells. Protein Engineering Design and Selection. 21(1). 1–10. 72 indexed citations

18.

Willemsen, Ralph A., C. P. M. Ronteltap, Patrick Chames, Reno Debets, & R. L. H. Bolhuis. (2005). T Cell Retargeting with MHC Class I-Restricted Antibodies: The CD28 Costimulatory Domain Enhances Antigen-Specific Cytotoxicity and Cytokine Production. The Journal of Immunology. 174(12). 7853–7858. 54 indexed citations

19.

Hülsmeyer, Martin, Patrick Chames, R.C. Hillig, et al.. (2004). A Major Histocompatibility Complex·Peptide-restricted Antibody and T Cell Receptor Molecules Recognize Their Target by Distinct Binding Modes. Journal of Biological Chemistry. 280(4). 2972–2980. 61 indexed citations

20.

Hoogenboom, Hennie R. & Patrick Chames. (2000). Natural and designer binding sites made by phage display technology. Immunology Today. 21(8). 371–378. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact